Literature DB >> 23706961

Comparison of plasma and cerebrospinal fluid levels of neuroactive steroids with their brain, spinal cord and peripheral nerve levels in male and female rats.

Donatella Caruso1, Marzia Pesaresi, Federico Abbiati, Donato Calabrese, Silvia Giatti, Luis Miguel Garcia-Segura, Roberto Cosimo Melcangi.   

Abstract

Physiological changes and pathological alterations in the nervous system of rodents are associated with modifications in the levels of neuroactive steroids in the brain, spinal cord and/or peripheral nerves. Measures of tissue levels of steroids in the nervous system present serious limitations for human studies and for longitudinal studies in animals. In this study we have explored whether levels of neuroactive steroids in plasma and the cerebrospinal fluid reflect their levels in neural tissues. To this aim, we have evaluated by liquid chromatography-tandem mass spectrometry the levels of several neuroactive steroids in plasma, cerebrospinal fluid, cerebral cortex, cerebellum, hippocampus, spinal cord and sciatic nerve of male and female rats. Data indicate that plasma and cerebrospinal fluid levels of steroids do not fully reflect their tissue levels. However, the interindividual variations in the levels of all the steroids assessed, with the exception of dehydroepiandrosterone, showed a positive correlation in plasma and cerebral cortex. Most steroids also showed a positive correlation in plasma and the cerebellum, the spinal cord and the sciatic nerve. In the hippocampus, the levels of tetrahydroprogesterone, testosterone and testosterone metabolites showed a significant positive correlation with their respective levels in plasma. The cerebrospinal fluid levels of some steroids, such as testosterone and dihydrotestosterone, showed a full correlation with tissue levels. In addition, cerebrospinal fluid levels of pregnenolone, progesterone, and 17β-estradiol showed a positive correlation with their corresponding levels in the majority of the neural structures analyzed. These findings suggest that the levels of some neuroactive steroids in cerebrospinal fluid as well as in plasma may be valuable to predict their levels in the nervous system.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Metabolism; Neurosteroids; Pregnenolone; Progesterone; Testosterone

Mesh:

Substances:

Year:  2013        PMID: 23706961     DOI: 10.1016/j.psyneuen.2013.04.016

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  43 in total

1.  Ethanol withdrawal-induced dysregulation of neurosteroid levels in plasma, cortex, and hippocampus in genetic animal models of high and low withdrawal.

Authors:  Jeremiah P Jensen; Michelle A Nipper; Melinda L Helms; Matthew M Ford; John C Crabbe; David J Rossi; Deborah A Finn
Journal:  Psychopharmacology (Berl)       Date:  2017-06-29       Impact factor: 4.530

Review 2.  Estrogens in Male Physiology.

Authors:  Paul S Cooke; Manjunatha K Nanjappa; CheMyong Ko; Gail S Prins; Rex A Hess
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

3.  Pregnenolone-progesterone-allopregnanolone pathway as a potential therapeutic target in first-episode antipsychotic-naïve patients with schizophrenia.

Authors:  HuaLin Cai; Xiang Zhou; George G Dougherty; Ravinder D Reddy; Gretchen L Haas; Debra M Montrose; Matcheri Keshavan; Jeffrey K Yao
Journal:  Psychoneuroendocrinology       Date:  2018-02-07       Impact factor: 4.905

4.  The perimenopausal aging transition in the female rat brain: decline in bioenergetic systems and synaptic plasticity.

Authors:  Fei Yin; Jia Yao; Harsh Sancheti; Tao Feng; Roberto C Melcangi; Todd E Morgan; Caleb E Finch; Christian J Pike; Wendy J Mack; Enrique Cadenas; Roberta D Brinton
Journal:  Neurobiol Aging       Date:  2015-04-01       Impact factor: 4.673

Review 5.  Adverse effects of common medications on male fertility.

Authors:  Mary K Samplaski; Ajay K Nangia
Journal:  Nat Rev Urol       Date:  2015-06-23       Impact factor: 14.432

6.  Age-specific associations between oestradiol, cortico-amygdalar structural covariance, and verbal and spatial skills.

Authors:  Tuong-Vi Nguyen; Sherri Lee Jones; Tricia Gower; Jimin Lew; Matthew D Albaugh; Kelly N Botteron; James J Hudziak; Vladimir S Fonov; D Louis Collins; Benjamin C Campbell; Linda Booij; Catherine M Herba; Patricia Monnier; Simon Ducharme; Deborah Waber; James T McCracken
Journal:  J Neuroendocrinol       Date:  2019-03-13       Impact factor: 3.627

7.  Sexually divergent changes in select brain proteins and neurosteroid levels after a history of ethanol drinking and intermittent PTSD-like stress exposure in adult C57BL/6J mice.

Authors:  Leslie L Devaud; Mehrdad Alavi; Jeremiah P Jensen; Melinda L Helms; Michelle A Nipper; Deborah A Finn
Journal:  Alcohol       Date:  2018-12-06       Impact factor: 2.405

8.  The perinatal effects of maternal caffeine intake on fetal and neonatal brain levels of testosterone, estradiol, and dihydrotestosterone in rats.

Authors:  S Karaismailoglu; M Tuncer; S Bayrak; G Erdogan; E L Ergun; A Erdem
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-05-29       Impact factor: 3.000

Review 9.  Pregnenolone sulfate as a modulator of synaptic plasticity.

Authors:  Conor C Smith; Terrell T Gibbs; David H Farb
Journal:  Psychopharmacology (Berl)       Date:  2014-07-06       Impact factor: 4.530

10.  Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia.

Authors:  Christine E Marx; Jimmy Lee; Mythily Subramaniam; Attilio Rapisarda; Dianne C T Bautista; Edwin Chan; Jason D Kilts; Robert W Buchanan; Eu Pui Wai; Swapna Verma; Kang Sim; Jayaraman Hariram; Rajesh Jacob; Richard S E Keefe; Siow Ann Chong
Journal:  Psychopharmacology (Berl)       Date:  2014-07-17       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.